Radioimmunoassay was compared to thin-layer and gasliquid chromatographic methods for detection of methadone in the urine of patients undergoing methadone maintenance therapy as treatment of heroin abuse. With urine samples known to contain methadone, 84% were positive by thin-layer chromatography as compared to 99% positives by the other two methods. This difference is attributed to the difference in sensitivity of the three methods. All three methods gave consistently positive results with urine samples from patients receiving 25 mg of methadone per day or more. With smaller daily doses the percentage of positive results obtained with thin-layer chromatography decreased. Analysis of urine samples not containing methadone showed no incidence of cross reaction of other drugs with the methadone radioimmunoassay. The methadone radioimmunoassay appears to be both sensitive and reliable; however, certain other factors limit its use as a primary screening method.
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The therapeutic use of methadone has necessitated routine analysis of urine samples from patients being treated for heroin abuse. Such urine surveillance must include analysis for illicit as well as prescribed medication such as methadone. The two major reasons for monitoring urine from these patients with respect to methadone are to detect use of illicitly obtained methadone and noncompliance with prescribed treatment (as when patients are selling all or part of their daily methadone dose).
Methadone or its metabolites in human urine can be detected by several methods. The most commonly used procedure is to extract the drugs from urine and separate and identify them by thin-layer chromatography (TLC) (1-5).' Gas-liquid chromatography (GLC) is also a sensitive and re-liable method for detecting methadone (5-7). Recently, a radioimmunoassay for methadone has been developed based on the same principle as the radioimmunoassays for morphine and barbiturates (8, 9) . Comparison of the barbiturate RIA to TLC and GLC showed that RIA was more sensitive and reliable than TLC and about equal to GLC (10) . However, since RIA's are more costly and are available for detection of only a few drugs, we have used RIA as a confirmation method for results obtained by TLC.
Here, our purpose was to compare the RIA for methadone with TLC and GLC as to sensitivity, reliability, and degree of interference by other drugs.
Materials and Methods

Subjects
Urine samples were from patients receiving treatment at the Veterans Administration Center. Urines were obtained from methadone patients about 24 h after the patients' last dose of methadone. Urine samples were also obtained from patients in other wards of the hospital who had no history of drug abuse but who were receiving various other drugs.
Each urine sample was divided for TLC, GLC, and RIA in a double-blind manner, so that results obtained with one method could not bias interpretation of results obtained with the other methods.
Analytical Procedures
Thin-layer chromatography.
Drugs were extracted from 50 ml of urine by a modified (5, 11, 12) were interpreted by the same technician. This method is sensitive to about 0.5 ig of methadone per milliliter of urine (5).
Gas-liquid chromatography.
Drugs were extracted from 5 ml of urine by the procedure of Goldbaum et al. (6) . Methadone and its major metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine were separated on a 90-cm column containing 3%-OV1 and detected with a flame ionization detector (5). With this method 0.02 g of methadone can be detected per milliliter of urine.
Radioimmunoassay.
The RIA kit we used was obtained Positive result by two different methods used as part of the criteria for a islne sample that actually contains methadone. C These urine samples from patients who were not supposed to be receiving methadone were positive by RIA and GLC.
from Roche Diagnostics, Nutley, N.J. 07110. It contained 20 ml of '251-labeled methadone, 20 ml of methadone-specific antibody,a drug-free urine, and a urine containing 0.1 sg of methadone per milliliter. Owing to the instability of 125I labeled methadone, the reagents were shipped and stored frozen. For use, the reagents were thawed and the 1251-labeled methadone and methadone-specific antibody solution were mixed; 0.4-ml portions were dispensed into 10 X 75 mm tubes, which were capped and stored at 4 #{176}C and used within two weeks.
The RIA for methadone was performed according to the manufacturer's directions for morphine and barbiturate RIA's. After processing, 0.5 nil of the RIA incubation mixture was added to 6 ml of modified Bray's solution and counted for 1 mm in a Tri-Carb Model 3330 liquid scintillation spectrometer ( Routinely, we assayed three urine standards by RLA and used the mean counts as the cutoff criterion for whether a sample was positive or negative.
Results
We analyzed a total of 221 urine samples for methadone by all three methods. A urine sample was considered to contain methadone if the patient's chart showed methadone administration within 24 h of the urine sample, and if any two of the three methods used gave positive results for methadone.
As shown in Table 1 , all 105 urine samples from patients receiving methadone were positive by at least two methods, thus meeting the criterion for urine samples known to contain methadone. Any negative results for methadone in this group of urine samples by any of the methods was therefore considered a falsely negative result. For TLC, GLC, and RIA the percentages of such falsely negative results were 14,0, and 1%, respectively. h of the time the urine sample was collected b These drugs or their metabolites were detected in the urine of certain patients and were not prescribed medications Figure 1 shows a plot of daily dose of methadone vs. percentage of positive results for each of the three methods. Both the GLC and RIA methods gave essentially 100% positive results for methadone over the entire dose range. With the TLC method 100% positive results were obtained when the daily methadone dose was 25 mg/day or more, but only 55 to 85% of the urine samples from patients receiving less than 25 mg of methadone per day were positive by TLC.
The lower part of Table 1 shows the results of analysis of the remaining 116 urine samples, which were all from patients who either had never received methadone or had not received it within 48 h of collection of the urine sample. Although none of these urines were positive by TLC, some were positive by GLC or RIA. All samples positive by RIA were also positive by GLC.
We studied the interference of other drugs with the methadone RIA by using urine samples from the patients who had never received methadone but who had received various other drugs (lower panel, Table 1 ). Table 2 shows a list of drugs that, ingested 24 h before the urine sample, did not cross-react with the methadone RIA to give a falsely positive result.
Discussion
By our criteria for urine samples that definitely contained methadone, both the RIA and GLC methods of methadone detection are evidently highly reliable (Table 1 , upper panel). The lower reliability of TLC (84% positive) appears to be related to the fact that it is the least sensitive of the three methods, because all the false negatives with TLC were obtained in urine samples from patients receiving less than 25 mg of methadone per day (Figure 1) . In a previous comparison of RIA with TLC and GLC methods for barbiturates, timed urine samples were obtained for five days after ingestion of barbiturate by a normal volunteer (10). Such an experimental design was impossible with methadone; however, urine samples were collected 1 h before methadone administration from one patient who was receiving 10 mg of methadone once a week, and again at 24-h intervals thereafter for three days. The pre-drug urine was negative by all three methods and TLC gave negative results on all urine samples from this patient. Both GLC and RIA were positive on the 24-and 48-h urine samples; however, only GLC was positive on the 72-h urine sample. These findings are consistent with the stated sensitivities of the three methods (see above). Of the 116 urines from patients who supposedly had not received methadone (Table 1 , lower panel), five were positive by both GLC and RIA. In routine surveillance, the fact that two completely independent methods of analysis were positive for methadone is sufficient to indicate the presence of methadone. Therefore, we have not classified these five as falsely positive results. An additional four urine samples were positive for methadone by GLC only. Because of the greater sensitivity of GLC it is possible that trace amounts of methadone were detected which were below the detection limits of RIA. However, without other supporting evidence these four positive results by GLC were considered falsely positive results. Although RIA's have been shown to cross-react with other drugs to give falsely positive results (5, 10, 13, 14) , no false positives were observed with the methadone RIA (Table 1 , lower panel) in the case of urines from patients who had received one or more of the drugs shown in Table 2 . Of these drugs we have observed that propoxyphene in high concentrations often interferes with detection of methadone by TLC and GLC. With urine from patients on both propoxyphene and methadone, we have observed tailing or streaked spots on TLC, which can decrease the detectability of methadone, and preliminary studies indicate that this interference is due to norpropoxyphene, the major propoxyphene metabolite in man (15) . With GLC, also, high-enough concentrations of propoxyphene or its metabolites can overlap those peaks used foE the determination of methadone. Propoxyphene and the norpropoxyphene that is present as a metabolite did not interfere with the methadone RIA, as shown in Table 2 . Because propoxyphene and methadone are chemically related, we also tested urine samples with added concentrations of propoxyphene as high as 1 mg/liter and found no cross reaction with the methadone RIA.
These data show that, based on its greater sensitivity and lack of interference, RIA is a more reliable method of methadone detection than TLC when the patient's daily dose of methadone is less than 25 mg per day. The methadone RIA, as designed, is slightly less sensitive than GLC; however, this difference is of little practical importance, because both methods can detect methadone in urine after low (2.5 to 5 mg) daily doses. Sensitivity and reliability are not the only factors determining the utility of an assay method. For routine surveillance, cost and versatility limit the use of RIA as a primary method of drug detection. We estimated previously that costs for labor and reagents for the RIA's of five different abusive drugs were about twice that for TLC and 1.5 times as much as GLC (10). Recently, Kaistha and Tadrus (16) estimated RIA to be five times more costly than TLC and about three times more costly than GLC. In addition, RIA lacks the inherent versatility of TLC or GLC, and at present, RIA's for only morphine, barbiturate, and amphetamine are commercially available, whereas RIA's for cocaine and methadone are being tested. Though RIA's could be developed for almost any abused drug, this is a lengthy procedure. In comparison, TLC and GLC can be used to detect a wide variety of drugs and can be easily modified for new drug assays in one's own laboratory.
For routine urine surveillance, TLC remains the primary method of choice, because it can detect the greatest number of drugs at the lowest cost with acceptable reliability. GLC is a good confirmation procedure, as is RIA. In confirming the presence of a single drug, the cost per urine sample for RIA is competitive with GLC. The methadone RIA, in particular, shows promise as a confirmation method, since, unlike TLC and GLC methods, propoxyphene or its metabolites do not interfere with methadone RIA. 16, 186 (1970) .
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Relationshipbetween Erythrocyte 2, 3-Diphosphoglycerate and Age in a Normal Population Anastasios Kalofoutis, Stefanos Paterakis, Antonios Koutselinis, and Vassilios Spanos
The concentration of 2,3-diphosphoglycerate in erythrocytes was determined in 369 male and 376 female normal subjects, 1 to 86 years of age, derived from the Greek population. It was inversely correlated (P < 0.01) with age. Persons over age 60 showed a decrease (P < 0.05) in 2,3-diphosphoglycerate concentrations as compared to those 1-20 years of age.
The concentration of 2,3-diphosphoglycerate (DPG) influences the affinity of hemoglobin for oxygen (1). Increased concentrations of DPG increase the release amount of oxygen available to the tissues, and there is an increase in erythrocyte DPG in response to hypoxia (2). Furthermore, an inverse correlation between DPG and hemoglobin has been reported, both for patients with anemia and normal persons (3-5).
Materials and Methods
In the present study, we estimated the concentration of erythrocyte DPG in 745 normal subjects (369 males and 376 females), 1 to 86 years of age, derived from the Greek population.
Blood was sampled early in the morning from these fasting subjects and transferred into siliconized tubes. We determined the concentration of DPG by the method of Krimsky (6). In addition, concentrations of serum iron, folate, and vitamin B12 were estimated by conventional methods. None of the subjects manifested any sign of illness nor were they seeking medical help. Special attention was paid to exclude persons with anemia (hemoglobin <134 g/liter for the males and <115 g/ liter for the females).
Results and Discussion
Studies on the metabolism of erythrocytes and DPG have shown that changes in hemoglobin concentration are closely related to changes in DPG concentration.
It is well known that several factors such as pH, temperature, and enzymes strongly influence the concentration of DPG in the glycolytic pathways that are affecting the capacity of oxygen release (7-9).
Our results are presented in Table 1 . The concentration of DPG in the erythrocyte decreases progressively with advancing age.
A significant (P <0.05) decrease in DPG was found in the last three groups, consisting of subjects older than 60 years, as compared to the two youngest groups. We also found a significant inverse correlation (P <0.01) between erythrocyte DPG concentration and age. The significance of the decreased erythrocyte DPG might be related to the lower concentration of plasma inorganic phosphate found in old age and under pathological conditions (10, 11) .
The negative correlation between DPG and hemoglobin concentration could also be the factor determining changes in the metabolic activity of the erythrocyte when hemoglobin is in its reduced form. It has been suggested (7) that the age of the erythrocyte may influence the concentration of DPG. This, however has not been worked out in relation to the effect of age on oxygen affinity. The present study possibly indicates that the decrease in DPG in some elderly subjects may be caused by a different behavior of the various glycolytic enzymes. This could be an early sign of disturbances in the mechanism of adaption to anemia or hypoxia related to age.
